IMNM Operating Cash Flow (Statement)
Immunome Inc · Operating Cash Flow (Statement)
IMNM Operating Cash Flow (Statement)
Latest reported-$61.69Mperiod ending
IMNM Quarterly Cash from Operations (-$2.33M → -$61.69M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
IMNM operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -61,692,000 | |
| -58,638,000 | |
| -47,953,000 | |
| -40,510,000 | |
| -49,401,000 | |
| -53,055,000 | |
| -42,060,000 | |
| -34,167,000 | |
| -23,397,000 | |
| -11,170,000 | |
| -17,459,000 | |
| -8,614,000 | |
| -5,668,000 | |
| 24,173,000 | |
| -6,683,000 | |
| -7,571,000 | |
| -8,060,000 | |
| -6,376,000 | |
| -6,805,000 | |
| -4,145,000 | |
| -3,741,000 | |
| -3,535,000 | |
| -6,062,000 | |
| -2,528,000 | |
| -1,480,000 | |
| -2,064,000 | |
| -2,579,000 | |
| -2,359,000 | |
| -2,331,000 | |
| -2,331,000 |